Skip to main content

Food Effect in Healthy Participants

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

ORIC Pharmaceuticals
1 program
1
ORIC-114Phase 11 trial
Active Trials
NCT06012721Completed32Est. Nov 2023
Crestone
CrestoneCO - Boulder
1 program
CRS3123 200 mg capsulePHASE_1
Eisai
EisaiChina - Liaoning
1 program
E7386PHASE_11 trial
Active Trials
NCT03996226Completed17Est. Oct 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ORIC PharmaceuticalsORIC-114
EisaiE7386

Clinical Trials (2)

Total enrollment: 49 patients across 2 trials

Effect of Food on the Pharmacokinetics of ORIC-114

Start: Sep 2023Est. completion: Nov 202332 patients
Phase 1Completed

A Food-Effect Study of E7386 in Healthy Participants

Start: Jun 2019Est. completion: Oct 201917 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.